Mustafa Tükenmez

Istanbul University — Turkey

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index847citations96works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(47), Breast Lesions and Carcinomas(31), Breast Implant and Reconstruction(14), Cancer and Skin Lesions(13), Cancer Treatment and Pharmacology(11)

Publications96 total

Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a
Current Oncology·2025Open Access
Loco-Regional Treatment in De Novo Bone Only Metastatic Breast Cancer; Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a
Preprints.org·2025Open Access
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons
Langenbeck s Archives of Surgery·2025· 1 citedOpen Access
Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study
Clinical Cancer Research·2025
Role of Lymphoscintigraphy in Repeat Sentinel Lymph Node Biopsy for cN0 Ipsilateral Breast Cancer Recurrence
Molecular Imaging and Radionuclide Therapy·2025Open Access
ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03
Annals of Surgical Oncology·2025
Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study
Clinical Breast Cancer·2025· 3 cited
Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study
European Journal of Surgical Oncology·2025· 3 cited
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer
JAMA Surgery·2025· 14 citedOpen Access
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03
Annals of Surgical Oncology·2024· 7 cited
Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided
Cancer·2024· 6 citedOpen Access
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
World Journal of Surgical Oncology·2024· 9 citedOpen Access
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy
2024Open Access
Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy
World Journal of Surgical Oncology·2024· 4 citedOpen Access
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer
Cancers·2024· 2 citedOpen Access
Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study
Cancer Research·2024· 2 cited
Abstract PO4-28-04: Curcumin inhibits breast cancer cell proliferation by regulating ciRS-7/miR-7-5p/CKS2 axis
Cancer Research·2024
Abstract PO4-12-03: PATIENT REPORTED OUTCOMES IN TERMS OF ARM AND SHOULDER FUNCTIONS AND QUALITY OF LIFE AND LYMPHEDEMA ARE AFFECTED BY THE STAGE, AND EXTENT OF AXILLARY SURGERY IN THE EARLY POSTOPERATIVE PERIOD OF PATIENTS WITH BREAST CANCER
Cancer Research·2024· 1 cited
Abstract PO4-23-01: Imaging tailored axillary approach combined with radiotherapy eliminates axillary lymph node dissection in low-volume axillary disease after neoadjuvant chemotherapy
Cancer Research·2024
Abstract PO5-05-12: Loco-regional Treatment in De Novo Bone Only Metastatic Breast Cancer; Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a
Cancer Research·2024
page 1 of 5Next →

Frequent Co-authors

Neslihan Cabıoğlu(37), Mahmut Müslümanoğlu(29), Vahit Özmen(27), Abdullah İğci(26), Selman Emiroğlu(22), Hasan Karanlık(20), Enver Özkurt(19), Semen Önder(16), Ravza Yılmaz(12), Adnan Aydıner(12), Serdar Özbaş(7), Aykut Soyder(7), Gizem Öner(7), Ekrem Yavuz(7), Aysel Bayram(7), Atilla Soran(6), Didem Can Trabulus(6), Ahmet Dağ(6), Mehmet Ali Gülçelik(6), Levent Yenıay(6)